Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22367,117,1.38 [1.15-1.65],0.0004942596698365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,22478,115,2.36 [1.83-3.03],2.5328510943501287e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,19439,99,0.48 [0.29-0.80],0.0045468856621143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,23012,120,2.55 [1.78-3.67],4.115489292544245e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",22478,115,1.59 [1.23-2.06],0.000439226871471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,22738,117,4.51 [2.59-7.84],1.0083236449585766e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,22927,121,1.53 [1.21-1.94],0.0003621575307889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19384,97,1.69 [1.25-2.30],0.000669432168837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19439,99,1.61 [1.24-2.09],0.0004102423363069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19900,99,3.02 [1.83-5.00],1.6833812446421184e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,23189,120,0.32 [0.16-0.65],0.0013869172067836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,22835,117,2.15 [1.43-3.24],0.0002551664785613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,20004,99,3.84 [2.31-6.38],1.942914073540933e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,19568,96,2.02 [1.27-3.24],0.0032086722220052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,22835,117,1.43 [1.13-1.81],0.0026036305750152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,19568,96,1.46 [1.16-1.84],0.0012458190864985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22478,115,1.33 [1.10-1.59],0.002620427480798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,23120,121,6.47 [3.62-11.57],2.8430285033065797e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,22182,109,1.33 [1.13-1.55],0.0004952410227345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,23024,120,2.32 [1.54-3.51],6.587891656212175e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,22927,121,1.44 [1.19-1.73],0.0001214831556554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK2,Protein AHNAK2,19498,94,2.69 [1.64-4.40],8.058357498661936e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22834,121,1.57 [1.35-1.84],1.2128832881414355e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",22835,117,1.34 [1.19-1.51],1.0063871269780652e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,23086,120,3.57 [1.60-7.98],0.001926592544383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,23120,121,2.00 [1.37-2.91],0.0003305665233222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,23120,121,1.97 [1.37-2.85],0.0002799292011144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANPEP,Aminopeptidase N,22938,119,2.50 [1.53-4.11],0.0002814652358771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,22375,115,1.44 [1.21-1.72],3.595306149057607e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22835,117,1.50 [1.11-2.02],0.0080213866298829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA2,Apolipoprotein A-II,20025,100,1.74 [1.19-2.53],0.0040281377264323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,22835,117,1.85 [1.42-2.41],5.335853959102784e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,22775,117,3.40 [2.10-5.52],7.330924316869511e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,20025,100,3.35 [1.76-6.38],0.000236476649541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,19900,99,1.65 [1.18-2.30],0.0030320626332935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,20043,98,1.74 [1.26-2.40],0.0008544464438194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19498,94,2.99 [1.71-5.22],0.0001235013694449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",23024,120,2.74 [1.56-4.81],0.0004321633730413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22367,117,1.59 [1.26-2.01],9.968442840895109e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,22367,117,2.00 [1.26-3.19],0.0034879297908279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,22775,117,0.51 [0.31-0.83],0.0064787887475484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22868,121,1.96 [1.29-2.98],0.0015598462097485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,22846,119,1.54 [1.18-2.03],0.0017460005577655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,23103,119,7.97 [4.03-15.77],2.4725095601611582e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,23124,119,1.85 [1.51-2.26],2.0800968323580616e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,23024,120,2.79 [1.58-4.92],0.0003858319947478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,22868,121,1.76 [1.25-2.47],0.0010843525414572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22980,119,1.62 [1.15-2.28],0.0060031162092026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,19555,95,4.38 [2.37-8.07],2.2737681892524085e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,23120,121,0.49 [0.31-0.77],0.0022242104490039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",22478,115,1.34 [1.14-1.56],0.0003367842313037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,23120,121,1.80 [1.32-2.45],0.0002291183066909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,22728,117,1.63 [1.32-2.03],8.488977877723277e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,22733,117,1.64 [1.28-2.11],0.00010571807085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,23120,121,0.27 [0.17-0.43],4.5813508271043394e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,19498,94,1.75 [1.28-2.38],0.0004207050771413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,22927,121,1.95 [1.27-2.99],0.0021725523266968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,23189,120,1.85 [1.35-2.54],0.0001303259846807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,23189,120,2.18 [1.59-3.00],1.5273184840224206e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,23141,119,1.27 [1.08-1.49],0.0032669920676962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,23024,120,1.67 [1.31-2.15],4.8504181057270734e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,22801,121,1.41 [1.11-1.79],0.0045291479845253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,22868,121,1.28 [1.06-1.54],0.0089290780199352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,23154,119,1.99 [1.34-2.95],0.0006622636578513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,22404,119,2.68 [1.93-3.71],2.8175902337665566e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,22980,119,1.76 [1.22-2.53],0.0024991089114933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD207,C-type lectin domain family 4 member K,22471,117,2.04 [1.35-3.08],0.0007141859418073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD226,CD226 antigen,19439,99,0.50 [0.31-0.81],0.0050279435548883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,22985,119,1.81 [1.24-2.64],0.0022560750674787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,22775,117,1.80 [1.20-2.70],0.0047234008831973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,22916,119,2.10 [1.32-3.34],0.0016469856965397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300A,CMRF35-like molecule 8,19568,96,2.33 [1.24-4.40],0.0089193638300144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,23124,119,2.29 [1.48-3.53],0.0001829123804295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,23040,121,2.33 [1.64-3.32],2.807603321671175e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,22835,117,3.94 [2.60-5.99],1.3065201308313982e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,22835,121,1.65 [1.18-2.29],0.0032471952915448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD48,CD48 antigen,22984,120,2.78 [1.60-4.81],0.0002662948942027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,22061,116,2.75 [1.60-4.73],0.0002555025993885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,23124,119,2.08 [1.35-3.19],0.0008164896540334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,20004,98,3.17 [1.98-5.07],1.4651871096883903e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,22868,121,3.04 [2.03-4.56],6.610968831465853e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD93,Complement component C1q receptor,22025,114,1.93 [1.18-3.15],0.0091382353653652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,22775,117,1.83 [1.37-2.45],4.526297486686202e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,22927,121,2.52 [1.60-3.97],6.131359228791462e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,22835,117,1.43 [1.16-1.76],0.000748513388368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,22927,121,0.52 [0.35-0.76],0.0007127948501409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,22958,120,2.44 [1.31-4.54],0.0048860846390811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22947,117,3.91 [1.92-7.95],0.0001635086926492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19900,99,0.71 [0.57-0.89],0.0026309758126633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19612,99,1.59 [1.19-2.14],0.0018923562651867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,22086,114,1.47 [1.20-1.81],0.0002586957292868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,20004,99,1.92 [1.36-2.71],0.0002031927838219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22478,115,1.49 [1.10-2.02],0.0091101209542287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,20004,99,0.62 [0.46-0.84],0.0016729521023934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,23144,119,0.60 [0.45-0.80],0.0005140187449255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,22927,121,2.00 [1.40-2.85],0.0001404968025476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19967,101,2.48 [1.72-3.57],1.0500225656924892e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,19897,101,2.03 [1.31-3.14],0.0014024483650888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,20004,99,1.73 [1.48-2.03],6.462298603642136e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,22375,115,1.64 [1.38-1.96],3.737843666679923e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,22984,120,2.38 [1.43-3.96],0.0008030966667595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,20004,99,1.67 [1.16-2.41],0.0062021822801167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,23032,119,3.07 [1.92-4.90],2.79609530740392e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,20004,99,1.55 [1.12-2.13],0.0073747940716769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,22775,117,1.90 [1.20-3.00],0.0058132207179579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,22912,118,2.31 [1.41-3.77],0.0008300447214808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,22478,115,2.16 [1.35-3.45],0.0013025009505272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,22868,121,1.51 [1.18-1.92],0.0009746212359104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,22855,121,2.89 [1.74-4.81],4.416259588368314e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,22367,117,1.89 [1.38-2.60],7.367114164400725e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,19440,96,1.98 [1.40-2.81],0.0001275610891483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,23120,121,4.31 [2.12-8.77],5.506120760579756e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,23189,120,0.45 [0.25-0.82],0.0093806351658985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,22972,119,0.40 [0.25-0.64],0.0001004641775219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,22868,121,1.78 [1.25-2.52],0.0012193245480462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,20004,99,2.50 [1.31-4.76],0.0054852582535684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,22998,120,4.57 [2.34-8.94],8.980930217851051e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,22927,121,1.89 [1.29-2.77],0.0010345296715749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A4,Collagen alpha-4(IV) chain,19582,99,1.71 [1.14-2.58],0.009646785379612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,23189,120,2.78 [1.93-4.00],3.5476943459037686e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,22868,121,1.83 [1.35-2.48],8.924195183731515e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,22916,119,4.21 [2.41-7.35],4.5146696341269933e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19498,94,1.61 [1.14-2.28],0.0067458609820362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,23015,118,2.54 [1.63-3.94],3.4850672712576006e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,20004,98,2.57 [1.40-4.71],0.002229872226136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,22598,117,1.70 [1.14-2.53],0.0085840864482713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,19568,96,2.31 [1.39-3.86],0.0013340619701981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,22916,119,2.16 [1.21-3.85],0.0088038599972764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,23024,120,3.78 [2.00-7.15],4.1407145334782266e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,23024,120,3.63 [2.17-6.07],9.074202843060296e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22775,117,1.40 [1.09-1.79],0.0075855114878402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,22946,118,3.15 [1.94-5.10],3.077470758797192e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,22572,118,1.82 [1.28-2.58],0.0009404278781994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTBS,Di-N-acetylchitobiase,19743,100,4.19 [2.07-8.46],6.592772802253938e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,20004,99,2.96 [1.64-5.34],0.0003335679006014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRC,Chymotrypsin-C,22919,120,0.50 [0.39-0.62],2.979253506576024e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,19967,101,0.54 [0.41-0.72],1.330012720415549e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,21387,114,2.14 [1.57-2.92],1.3825407451418649e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,22927,121,4.70 [2.57-8.59],4.844706506437296e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSS,Cathepsin S,17978,92,4.17 [1.89-9.19],0.0004039982770482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,22898,119,2.35 [1.43-3.85],0.0007075651970015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,22868,121,1.71 [1.32-2.22],4.907614604808626e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,23148,120,3.21 [1.65-6.23],0.0005932077999063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,23141,119,1.91 [1.46-2.51],2.74804862158394e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,22727,119,1.40 [1.17-1.68],0.0002849317417464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,23024,120,1.57 [1.29-1.91],7.166770103228398e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22835,117,1.62 [1.17-2.23],0.003552574544226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,22420,117,1.41 [1.09-1.83],0.0089237564461568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK4,Dickkopf-related protein 4,22738,117,1.47 [1.10-1.96],0.0099062440227079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,22985,119,2.66 [1.59-4.45],0.0001873464848294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,23042,121,1.43 [1.13-1.81],0.0029337098818811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSC2,Desmocollin-2,22670,118,1.91 [1.32-2.77],0.000637297635298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,19861,101,1.77 [1.21-2.61],0.0035773006273923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,22835,117,3.73 [2.10-6.65],7.826281481873731e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,23120,121,2.79 [1.97-3.95],8.247894023063099e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,22868,121,0.76 [0.64-0.92],0.0037069230396698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22478,115,1.83 [1.24-2.70],0.0023154616938183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,19498,94,4.02 [2.24-7.23],3.2184470044102763e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22939,119,2.17 [1.32-3.57],0.0022425030513875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFHD1,EF-hand domain-containing protein D1,19980,101,1.86 [1.26-2.75],0.0016918120856489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,22874,118,2.21 [1.27-3.85],0.0048799230698628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,22738,117,3.05 [1.99-4.66],2.8670936354383737e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,23189,120,0.19 [0.07-0.50],0.0008921331333292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,22868,121,1.39 [1.13-1.72],0.0023362740333379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,22198,113,1.42 [1.18-1.72],0.0002578723702224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22367,117,1.71 [1.21-2.40],0.002202968429604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22478,115,5.05 [2.49-10.24],6.969035595975616e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,22140,114,2.90 [2.03-4.15],4.9996697367834594e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,23189,120,3.44 [2.02-5.85],5.197334704840231e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,22868,121,1.37 [1.17-1.59],6.883426256892515e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPPK1,Epiplakin,19498,94,1.39 [1.09-1.76],0.0075247705465383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,23078,121,2.66 [1.69-4.20],2.4115616771681164e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,22942,119,3.92 [1.64-9.37],0.0021660344133321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",22916,119,1.49 [1.28-1.74],3.593740005290623e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",23189,120,1.92 [1.43-2.58],1.7040260491210277e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,20004,98,2.60 [1.45-4.66],0.0013065406224356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,22890,121,2.42 [1.46-4.01],0.000605129281766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,23117,120,1.96 [1.48-2.61],3.032797334916185e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",22927,121,1.50 [1.24-1.82],3.629120814879494e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,22868,121,1.86 [1.32-2.61],0.0003642820753688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,22367,117,1.39 [1.11-1.75],0.0043514546295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,23084,121,1.34 [1.18-1.51],2.724497151481402e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,23088,121,1.46 [1.23-1.73],1.2257674457848012e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,22985,119,4.92 [2.57-9.42],1.5738506278166723e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,20025,100,2.28 [1.72-3.04],1.4840216264197792e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,19498,94,4.46 [2.26-8.81],1.6457774366863606e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,22886,120,3.37 [2.24-5.09],6.786689140754658e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,19931,101,1.33 [1.08-1.64],0.0064525424911469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,19568,96,1.77 [1.34-2.32],4.6598075785587777e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,23124,119,2.15 [1.55-2.99],4.776919774978712e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22835,117,2.94 [1.72-5.01],7.388292801330709e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,23036,120,2.67 [1.45-4.92],0.0015867850213917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,19967,101,1.52 [1.36-1.70],6.04143154643918e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP1,Guanylate-binding protein 1,19934,101,1.62 [1.24-2.12],0.0003834827216923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,19118,93,1.71 [1.26-2.30],0.0004680298967346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,23189,120,2.03 [1.67-2.47],8.796290137745664e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,23084,121,3.10 [1.84-5.22],2.0575281682987613e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,22874,118,2.00 [1.54-2.59],2.005517399183082e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,22775,117,3.22 [1.76-5.91],0.0001560678023109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIP,Gastric inhibitory polypeptide,19498,94,1.81 [1.29-2.55],0.0006775682980112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,19967,101,2.52 [1.41-4.48],0.0017334164391788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GKN1,Gastrokine-1,21936,113,2.92 [1.76-4.84],3.264634208722909e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,19530,96,2.31 [1.41-3.78],0.0008414846990335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,19513,97,1.56 [1.14-2.14],0.0056933890516117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",20004,99,1.94 [1.39-2.71],0.0001054972274581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,22775,117,0.66 [0.49-0.88],0.004922817201099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,19897,101,2.03 [1.51-2.73],2.595226466478664e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,22375,115,1.85 [1.24-2.74],0.0024557833006606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,19900,99,1.69 [1.26-2.26],0.0004052014584261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,22478,115,1.57 [1.23-2.01],0.000310964877618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,19897,101,1.59 [1.26-1.99],6.514221019253248e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,22801,118,2.80 [1.52-5.17],0.0009532158400996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",22835,117,1.69 [1.36-2.09],1.4453192452474564e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,19965,100,0.46 [0.26-0.82],0.0089333664957923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,23012,120,1.66 [1.30-2.13],5.511720844513197e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,23120,121,1.20 [1.07-1.34],0.0019892163149463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,23086,120,1.99 [1.60-2.48],5.854055614795346e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,22912,118,2.69 [1.73-4.18],1.0594002908880104e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,19568,96,2.77 [1.40-5.47],0.0032750573747745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,23141,119,2.81 [1.85-4.25],1.08664823052056e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,19930,101,1.59 [1.18-2.16],0.0026994978082535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19980,101,2.42 [1.31-4.47],0.0045876338811584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22809,119,1.92 [1.25-2.94],0.0029928624008581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22868,121,2.89 [1.77-4.71],2.1593038270086635e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX1,Heme oxygenase 1,22664,120,1.52 [1.11-2.09],0.0096398198147934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,22375,115,1.67 [1.28-2.18],0.000146822524938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,22660,117,1.68 [1.20-2.35],0.0026177029768102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,22367,117,0.47 [0.30-0.74],0.0010609567158457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,22835,117,1.88 [1.25-2.82],0.0024401597727833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22714,119,3.10 [1.95-4.93],1.571653847369904e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,22752,119,2.71 [1.51-4.86],0.0008673099603601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,22798,119,2.74 [1.69-4.43],3.986682689856125e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,22927,121,1.73 [1.21-2.48],0.0027927490872432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19406,97,3.22 [2.23-4.66],5.559604123189331e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,23146,120,1.46 [1.12-1.91],0.0050346457544041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,22606,115,2.34 [1.74-3.16],2.4196874769430364e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,23189,120,2.29 [1.54-3.41],4.735687938889853e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,22927,121,3.44 [2.32-5.10],7.276578451114779e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,22835,117,1.94 [1.47-2.57],3.7656532323452383e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,20004,98,1.38 [1.10-1.72],0.0053546013307916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10,Interleukin-10,22462,118,1.26 [1.08-1.47],0.0041765781001742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,23024,120,3.20 [2.12-4.82],2.5582313450099826e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,22868,121,2.71 [1.77-4.15],4.755016417049413e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17A,Interleukin-17A,22435,118,1.53 [1.12-2.09],0.0079821360930128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,22462,118,1.42 [1.17-1.72],0.0004484891753859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,22838,119,1.72 [1.27-2.32],0.0004466878972886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,22980,119,2.96 [1.87-4.69],3.783337921329857e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,23141,119,3.22 [2.08-4.99],1.4849534180841904e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,22356,119,1.78 [1.46-2.17],1.4934493785493623e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,22874,118,3.84 [1.91-7.72],0.0001630889472483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,22912,118,0.54 [0.36-0.82],0.0035146284313347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,23117,120,2.25 [1.58-3.21],7.672160400439122e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,22462,118,0.59 [0.40-0.87],0.0071451660589657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,22876,120,1.52 [1.20-1.92],0.00057601149399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RB,Interleukin-20 receptor subunit beta,19439,99,1.76 [1.22-2.53],0.00255906655411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,19897,101,1.91 [1.59-2.30],9.577593205627752e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,22738,116,2.53 [1.76-3.62],4.420045775646745e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,22868,121,1.88 [1.38-2.56],5.453110856460866e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,22868,121,2.62 [1.84-3.72],7.816580478937151e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,22835,117,1.47 [1.28-1.70],1.197242123062092e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,22927,121,4.28 [1.76-10.43],0.0013666480900821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,19897,101,1.68 [1.25-2.25],0.0005049307059209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,19568,96,1.73 [1.21-2.46],0.0024624824130376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,19900,99,1.33 [1.11-1.60],0.0025432841204279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,22835,117,1.47 [1.12-1.93],0.0053062943806243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM1,Isthmin-1,22868,121,1.71 [1.14-2.57],0.0088762059111272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA2,Integrin alpha-2,19568,96,0.39 [0.22-0.69],0.00139737579257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM2,Junctional adhesion molecule B,23124,119,2.13 [1.20-3.77],0.0097532834237583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JUN,Transcription factor AP-1,22462,118,1.35 [1.08-1.69],0.0085792342118199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF1C,Kinesin-like protein KIF1C,19384,97,1.65 [1.22-2.24],0.001052347641352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,22927,121,0.46 [0.32-0.68],9.791521561001429e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,22773,118,2.19 [1.50-3.19],4.333630976921317e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK13,Kallikrein-13,22450,113,1.88 [1.30-2.71],0.0007176581693886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK14,Kallikrein-14,23120,121,1.73 [1.25-2.41],0.0010161484840707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",22835,117,1.39 [1.17-1.66],0.0002464267200646
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",22834,121,1.51 [1.22-1.87],0.000141396667555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,23141,119,1.83 [1.33-2.53],0.0002475111623418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22916,119,2.21 [1.62-3.03],7.545872529733876e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,23103,119,1.79 [1.37-2.32],1.3792719815665814e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,22728,117,2.84 [1.88-4.28],6.178933095195655e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,22980,119,1.50 [1.17-1.92],0.0014815783173071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,22203,117,1.79 [1.25-2.56],0.0015772043992407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,22968,119,2.16 [1.32-3.56],0.0023057646517762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,22916,119,2.02 [1.54-2.65],3.517953609889823e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,22912,120,3.87 [2.50-6.00],1.352802361930846e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,23024,120,2.58 [1.70-3.92],8.232847615185568e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22890,121,2.29 [1.37-3.81],0.0014857659351248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,19967,101,2.52 [1.40-4.55],0.0021604063010969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,22835,117,1.51 [1.19-1.92],0.0007678526790286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPL,Lipoprotein lipase,22927,121,1.72 [1.19-2.47],0.0035834696983874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,20043,98,3.51 [1.83-6.75],0.0001608773941701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,22927,121,2.28 [1.49-3.48],0.0001420940567503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,22835,117,2.14 [1.56-2.93],2.3701403618611083e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,22462,118,0.45 [0.30-0.69],0.0002070682255229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSP1,Lymphocyte-specific protein 1,22868,121,1.70 [1.17-2.49],0.0058060706806678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,23189,120,2.25 [1.40-3.61],0.0008395392456617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,22808,119,3.77 [2.35-6.05],4.038109521015873e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY6D,Lymphocyte antigen 6D,22801,120,1.85 [1.29-2.65],0.0008371184434985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,22775,117,2.02 [1.36-3.02],0.0005532919172535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,22367,117,1.56 [1.24-1.97],0.0001740590862721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22690,117,1.49 [1.18-1.89],0.0009392377382704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC2,MAM domain-containing protein 2,20004,98,2.29 [1.39-3.78],0.0011625540043976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,22958,120,2.49 [1.46-4.25],0.0008240578775971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,22927,121,0.77 [0.68-0.88],0.0001031531068011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MERTK,Tyrosine-protein kinase Mer,23141,119,2.50 [1.40-4.45],0.0019390799147709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MILR1,Allergin-1,22462,118,1.49 [1.10-2.01],0.0094899018039338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,22835,117,1.55 [1.29-1.85],1.777161957675848e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,22886,120,1.44 [1.14-1.83],0.0021533647740456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,22931,119,1.99 [1.51-2.62],8.090855785850361e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,22912,118,1.58 [1.16-2.16],0.0040656841288884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,22440,115,2.44 [1.70-3.50],1.3210294223062292e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,23087,119,1.39 [1.13-1.72],0.0019137311406776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,22897,121,1.20 [1.05-1.38],0.0084946277285307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,20025,100,4.71 [2.68-8.28],7.606592356877116e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,22802,117,1.51 [1.20-1.90],0.0004333046210638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,22834,119,1.64 [1.30-2.07],2.6738061365249207e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,23124,119,2.42 [1.71-3.42],5.271007966598943e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,22478,115,0.61 [0.44-0.85],0.0035914527944427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,19612,99,1.65 [1.31-2.09],2.798450042633953e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,22462,118,1.33 [1.09-1.63],0.0059525724973485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,22998,120,1.63 [1.22-2.18],0.0008724680391435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19568,96,3.97 [1.58-9.97],0.0033953457360316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,22985,119,2.46 [1.36-4.43],0.0028164282698814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCF2,Neutrophil cytosol factor 2,22842,121,1.27 [1.08-1.50],0.0047050835488631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19900,99,2.24 [1.34-3.74],0.0021429835195404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCS1,Neuronal calcium sensor 1,23120,121,3.53 [2.03-6.13],7.297976323050447e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,22890,121,3.16 [2.00-4.99],7.561665791914923e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,22985,119,2.11 [1.39-3.20],0.0004485836991596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,22300,115,1.63 [1.13-2.34],0.0088028012358423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,22985,119,0.44 [0.31-0.65],2.5002057542203253e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,23141,119,2.85 [1.64-4.95],0.0001938296881048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22462,118,1.56 [1.26-1.93],5.0821639043883e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFIC,Nuclear factor 1 C-type,19980,101,1.54 [1.22-1.95],0.0002964084692026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,19104,94,2.95 [1.54-5.62],0.0010560896481238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NINJ1,Ninjurin-1,22367,117,1.36 [1.08-1.71],0.0086763939927021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOMO1,Nodal modulator 1,22912,118,2.76 [1.51-5.08],0.0010356415068883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",22375,115,1.45 [1.13-1.86],0.0031418128864044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,19669,98,2.49 [1.67-3.71],7.899210864788972e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,22927,121,2.50 [1.71-3.66],2.4627543997753856e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,22478,115,1.33 [1.15-1.53],7.770462812204812e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX2,Neuronal pentraxin-2,20004,99,2.16 [1.22-3.82],0.0084916827848035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,19967,101,2.25 [1.57-3.22],8.810688950245739e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,22985,119,1.69 [1.34-2.14],1.189328334559053e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,22927,121,1.46 [1.26-1.70],4.02820465086657e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,19980,101,2.89 [2.10-3.99],9.373086002830179e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGN,Mimecan,22912,118,1.80 [1.22-2.64],0.0028015580354336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,22958,120,2.18 [1.33-3.57],0.0021102667900201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,22760,119,1.36 [1.10-1.69],0.005505310293406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,23020,119,2.81 [1.35-5.86],0.0057746224359407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,19967,101,3.01 [2.12-4.26],6.582380582087478e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19529,96,1.79 [1.26-2.56],0.0012875061758979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,22927,121,2.08 [1.22-3.56],0.0074504537147989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19439,99,1.94 [1.41-2.66],4.147948701118853e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,20025,100,2.07 [1.58-2.72],1.5082013933989036e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,23141,119,1.97 [1.38-2.82],0.0001911400814097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22775,117,3.02 [1.71-5.34],0.0001491950325892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,22601,116,1.74 [1.37-2.20],4.470455807290978e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,22621,117,3.03 [2.12-4.32],9.731330941171615e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22912,118,2.47 [1.44-4.22],0.0009516541459705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,22912,118,1.91 [1.27-2.86],0.0017280855734292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,22985,119,3.69 [2.10-6.46],5.319476885244285e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,23147,120,0.40 [0.29-0.56],9.572974909746321e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,23117,120,1.90 [1.37-2.63],0.0001239561517664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,22770,119,5.33 [3.27-8.69],1.9806977346056755e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,23080,120,2.67 [1.38-5.14],0.0034057708385782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,20025,100,0.56 [0.42-0.77],0.0002348351883916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22835,117,2.09 [1.54-2.85],2.784359850318451e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POMC,Pro-opiomelanocortin,19498,94,0.66 [0.49-0.89],0.0057616504976425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,22478,115,2.23 [1.40-3.55],0.0007118205875736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPL,Periplakin,19439,99,2.15 [1.47-3.16],8.471265018874881e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,20004,99,2.90 [1.79-4.69],1.4671880010933055e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,23042,120,2.27 [1.48-3.46],0.0001553940377158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRND,Prion-like protein doppel,19967,101,1.75 [1.28-2.38],0.000435539425042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,19439,99,1.79 [1.30-2.48],0.0003784240665017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,22835,120,2.34 [1.66-3.30],1.3650249305959612e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRUNE2,Protein prune homolog 2,19612,99,1.96 [1.30-2.95],0.0013044221727142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,19811,98,2.15 [1.34-3.43],0.0013831490315106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,22478,115,1.63 [1.20-2.23],0.0019145736136937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,22868,121,1.69 [1.16-2.47],0.0061050211380061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,23124,119,2.16 [1.50-3.10],3.288847460743352e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXN,Paxillin,22375,115,1.57 [1.23-2.01],0.0003218360720624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYY,Peptide YY,19384,97,1.30 [1.07-1.57],0.0077291324615244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6A,Ras-related protein Rab-6A,22868,121,0.53 [0.37-0.76],0.0004488117252332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALY,RNA-binding protein Raly,19897,101,1.48 [1.12-1.96],0.0065106772730972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,23020,119,1.56 [1.15-2.11],0.0041190766178135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,19980,101,2.36 [1.71-3.25],1.3470698534642664e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,22835,117,1.37 [1.12-1.68],0.0024141915092183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,22835,117,1.63 [1.28-2.08],7.33291550172433e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,22760,119,1.66 [1.25-2.19],0.0004120762355357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,23189,120,1.46 [1.14-1.88],0.0028291921912804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,23189,120,1.61 [1.28-2.03],6.047680142502401e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,22912,118,3.27 [1.98-5.39],3.572273523664688e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,22927,121,1.66 [1.38-2.00],7.875686031288136e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19568,96,1.62 [1.14-2.31],0.0071904980841898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,20025,100,2.27 [1.25-4.13],0.0074409161343262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,19498,94,1.64 [1.22-2.21],0.0010365133590944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,19879,100,2.65 [1.83-3.85],2.663765501526024e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,23076,120,2.73 [1.66-4.48],7.32894700938515e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,19498,94,3.43 [2.00-5.91],8.270029140229787e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,22367,117,1.38 [1.11-1.70],0.0031031611488803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARA5,Scavenger receptor class A member 5,23124,119,2.15 [1.26-3.69],0.0052860320011555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,22351,115,2.95 [1.92-4.52],7.292980293299039e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,23124,119,2.09 [1.20-3.65],0.0092654429016817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG2,Secretogranin-2,23014,119,1.93 [1.17-3.16],0.0095553848296074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,22952,120,0.57 [0.45-0.72],1.999700225501324e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,19568,96,3.56 [1.69-7.50],0.0008545481771512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,23050,120,2.08 [1.58-2.75],2.0330975497976202e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC4,Syndecan-4,22927,121,0.57 [0.40-0.80],0.001175991593128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDHB,Succinate dehydrogenase,19900,99,1.37 [1.10-1.71],0.0050355178568989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,23189,120,1.64 [1.17-2.29],0.003954228896741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,20043,98,0.24 [0.10-0.58],0.0015522670869784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,19930,101,2.29 [1.48-3.55],0.0002005567639133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA11,Serpin A11,23189,120,1.89 [1.24-2.85],0.0027463154991966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,23141,119,1.49 [1.21-1.83],0.0001578779863777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L2,Seizure 6-like protein 2,22835,117,2.28 [1.23-4.23],0.0091280252007201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,22701,117,1.62 [1.15-2.29],0.0064195341018748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP4,Secreted frizzled-related protein 4,19568,96,0.49 [0.31-0.77],0.0020167490539004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,22367,117,1.52 [1.17-1.98],0.0016717007636449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,20004,99,3.01 [1.93-4.70],1.2191136185773222e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,23024,120,2.37 [1.67-3.36],1.3189713152642089e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,22868,121,2.11 [1.34-3.33],0.0013575812486174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,22927,121,3.68 [2.20-6.16],7.601642975653335e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,19498,94,1.96 [1.28-2.99],0.0017975423535615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,23086,120,2.12 [1.22-3.69],0.0079505389374938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,22880,119,1.69 [1.18-2.42],0.0040979671644474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,22367,117,2.02 [1.48-2.75],8.221503884112218e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC28A1,Sodium/nucleoside cotransporter 1,19298,99,1.38 [1.09-1.75],0.0079855762801165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,23120,121,2.06 [1.29-3.29],0.0023118238545137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,23024,120,2.09 [1.45-3.03],9.064547361831106e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,23012,119,1.69 [1.25-2.30],0.0007638548111065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",22912,118,1.65 [1.15-2.39],0.0072408713957437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,22367,117,1.94 [1.25-3.01],0.0029850829979964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,22912,118,1.66 [1.22-2.26],0.0013253078312298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,22868,121,1.45 [1.15-1.82],0.0016512150142134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,22846,118,2.09 [1.31-3.33],0.0019835996838429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,22958,120,2.32 [1.56-3.44],3.205818615462963e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,22815,119,3.48 [2.33-5.19],1.0068598654172101e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22890,121,0.74 [0.63-0.88],0.0007657855690539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",23189,120,2.33 [1.38-3.93],0.0014804688128439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,23124,119,1.65 [1.14-2.38],0.0074926634735277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,22868,121,1.50 [1.21-1.86],0.000182556230178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SWAP70,Switch-associated protein 70,19900,99,1.65 [1.14-2.38],0.0082716996257424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,20323,105,1.97 [1.19-3.25],0.0080645002446576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,22835,117,2.25 [1.52-3.33],5.308441937272663e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,20004,98,1.93 [1.20-3.11],0.0069997643042732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,20004,98,2.81 [1.47-5.39],0.0018122302816852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,22795,118,1.43 [1.20-1.72],9.134293281619334e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,22984,120,2.27 [1.84-2.81],2.5707517663474788e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,22866,117,1.51 [1.21-1.90],0.0002905096777886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,22907,119,1.64 [1.33-2.03],3.979171078713218e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,22868,121,1.57 [1.17-2.11],0.0026287149304484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,22985,119,2.67 [1.79-3.97],1.2822026897767285e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,23189,120,2.50 [1.50-4.16],0.0004231783067878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,22912,118,2.31 [1.65-3.24],1.3185487014478288e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THY1,Thy-1 membrane glycoprotein,23124,119,2.41 [1.40-4.17],0.0015821561388844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,22633,117,2.68 [1.62-4.42],0.000112022872436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,22912,118,2.67 [1.98-3.59],1.0715847387122776e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,22980,119,1.76 [1.25-2.47],0.001088442599708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22775,117,2.92 [2.05-4.15],2.703375749984314e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22775,117,1.62 [1.33-1.96],9.847381311414736e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,23141,119,1.86 [1.27-2.72],0.0014782934928289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22916,119,3.52 [2.20-5.61],1.3931555542076118e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22985,119,2.64 [1.80-3.88],7.181591392586366e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22958,120,2.37 [1.45-3.87],0.0005942065282105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,23120,121,2.16 [1.40-3.33],0.0004706265341717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22912,118,3.16 [1.97-5.04],1.601050094188075e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22912,118,1.71 [1.33-2.20],3.333809324812977e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,23124,119,2.89 [1.64-5.10],0.000253742233915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,23103,119,2.17 [1.51-3.14],3.2270646184819345e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22775,117,2.27 [1.84-2.81],4.652150572659757e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,23124,119,1.66 [1.20-2.28],0.0019697657562463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22775,117,1.99 [1.42-2.79],5.896126505807988e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,23141,119,0.47 [0.27-0.81],0.007008637458609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,23024,120,2.84 [1.58-5.12],0.0004847024984177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,23148,120,2.89 [1.97-4.24],5.131675920537399e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,22770,119,1.60 [1.22-2.09],0.0006666599408889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,22916,119,1.67 [1.25-2.22],0.0004397242098331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,22985,119,2.21 [1.26-3.88],0.0056712525368452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,22927,121,2.16 [1.21-3.83],0.0088910236563101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19439,99,1.71 [1.21-2.41],0.0023553160827252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,22775,117,2.32 [1.57-3.44],2.5655888304031035e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,23121,119,0.60 [0.46-0.79],0.0001985310199145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPB1,Beta-ureidopropionase,20004,98,1.34 [1.11-1.62],0.002074065632821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,22478,115,1.55 [1.25-1.92],5.657297365552891e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAM1,Vascular cell adhesion protein 1,22942,119,2.10 [1.21-3.65],0.0085732689670431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIT,Vitrin,20004,98,2.43 [1.51-3.90],0.0002613009828339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,19897,101,2.30 [1.79-2.97],1.1688053611096715e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,22882,116,2.08 [1.43-3.03],0.0001256705813057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSNL1,Visinin-like protein 1,19967,101,2.04 [1.35-3.10],0.0007833256968006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,23084,121,2.22 [1.57-3.15],6.176489899002826e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,22691,117,1.86 [1.23-2.81],0.0033605295140268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,23085,120,1.47 [1.16-1.86],0.0012664117348397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,21736,112,2.81 [2.08-3.79],1.8299966592571832e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22705,117,0.34 [0.23-0.50],5.55050960928672e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,19967,101,3.33 [1.87-5.92],4.1875033245401056e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,22478,115,1.72 [1.30-2.28],0.0001530607328512
